Deltec Asset Management LLC Invests $2.46 Million in Semler Scientific, Inc. (NASDAQ:SMLR)

Deltec Asset Management LLC purchased a new stake in Semler Scientific, Inc. (NASDAQ:SMLR - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 45,600 shares of the company's stock, valued at approximately $2,462,000. Deltec Asset Management LLC owned 0.49% of Semler Scientific as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of SMLR. State Street Corp raised its stake in Semler Scientific by 0.6% in the 3rd quarter. State Street Corp now owns 118,223 shares of the company's stock worth $2,784,000 after purchasing an additional 725 shares in the last quarter. Quest Partners LLC lifted its position in shares of Semler Scientific by 48.0% during the 3rd quarter. Quest Partners LLC now owns 2,520 shares of the company's stock valued at $59,000 after acquiring an additional 817 shares during the period. US Bancorp DE increased its position in shares of Semler Scientific by 60.8% in the third quarter. US Bancorp DE now owns 3,064 shares of the company's stock worth $72,000 after purchasing an additional 1,158 shares during the period. Truvestments Capital LLC increased its holdings in Semler Scientific by 22.1% in the 3rd quarter. Truvestments Capital LLC now owns 14,661 shares of the company's stock valued at $345,000 after buying an additional 2,654 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its holdings in shares of Semler Scientific by 9.8% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 43,823 shares of the company's stock worth $1,032,000 after acquiring an additional 3,925 shares during the period. 49.37% of the stock is owned by institutional investors.

Semler Scientific Stock Performance

Shares of SMLR traded down $0.72 during mid-day trading on Friday, reaching $49.20. The company had a trading volume of 248,281 shares, compared to its average volume of 424,548. The company has a market capitalization of $456.08 million, a price-to-earnings ratio of 24.00 and a beta of 1.17. The company's 50 day simple moving average is $59.17 and its 200 day simple moving average is $41.49. Semler Scientific, Inc. has a 1-year low of $20.88 and a 1-year high of $81.56.

Wall Street Analysts Forecast Growth

Separately, Lake Street Capital boosted their price objective on shares of Semler Scientific from $40.00 to $71.00 and gave the company a "buy" rating in a research report on Friday, January 24th.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.